Physical and chemical properties of cigarette, heated tobacco and e-cigarette aerosols

Size: px
Start display at page:

Download "Physical and chemical properties of cigarette, heated tobacco and e-cigarette aerosols"

Transcription

1 SPS3 N2ff Physical and chemical properties of cigarette, heated tobacco and e-cigarette aerosols Caner U Yurteri, Jennifer Margham, Kevin McAdam, Mark Forster, Chuan Liu, Chris Wright, Derek Mariner, Chris Proctor and John McAughey EAC 2017 Special Session #3: Electronic Cigarettes Scientific Evidence Zürich, CH, Thursday 31 st August

2 Outline significant consumer-led growth for e-cigarettes over last 5 years diversity of products, now including tobacco heating products significant regulatory diversity as tobacco, consumer or pharmaceutical products in some cases prohibited or unregulated internal stewardship process products designed with appropriate stewardship; including assessment of chemical and physical emissions

3 Product categories

4 Product DIVERSITY The era of next generation nicotine delivery products

5 Approaches to modified risk assessment

6 Stewardship process Ingredient exclusion criteria : Non-threshold carcinogens Mutagens Genotoxicants Reproductive and developmental toxicants Respiratory sensitisers REACH List for Substances of Very High Concern Toxicological assessment of ingredient and any reaction / thermal breakdown products Toxicological Thresholds of Concern Approach 1.5 µg/day Costigan & Meredith (2015) Reg. Tox. Pharm. 72(2): Costigan & Lopez-Belmonte (2017) Reg. Tox. Pharm. 87: 1-8

7 Chemical characterisation 7

8 Are all aerosols the same? All are condensation aerosols Tobacco o C Tobacco < 250 o C Heat glycerol, PG, H 2 O, nicotine, < 250 o C Product of heating a material to form a vapour which supersaturates in air Mechanistically similar Physically and visually similar Compositionally and chemically very different

9 Chemical characterisation Untargeted emissions - GC x GC TOFMS analysis 3R4F mainstream cigarette smoke Chemical complexity changes across product categories Key activity is ID of new emissions and associated toxicological assessment *These qualities do not necessarily mean this product produces less adverse health effects than other tobacco products

10 Chemical characterisation Targeted emissions e.g. Vype epen2 Toxicants listed by regulators Other constituents of interest Of 142 constituents tested, most cigarette constituents were not detected in e-cigarette aerosol. Of those detected or quantified, a high proportion were attributable to laboratory air

11 Comparison between Vype epen and 3R4F 142 substances tested in aerosol and smoke On a per-puff basis the following reductions were observed. Such low abundances in e-cigarette aerosol present significant technical challenges to (a) measurement and (b) ensuring a clean chemical background *These qualities do not necessarily mean this product produces less adverse health effects than other tobacco products Margham et al (2016) Chem. Res. Toxicol. 29: Forster et al (2017) Reg. Tox. Pharm., submitted 11

12 Physical characterisation 12

13 Physical characterisation Common puff & dilution engine for constant volume sampling (Cambustion SCS) Electrical mobility spectrometry : Cambustion DMS-500 Laser diffraction : Malvern Spraytec Cascade impaction : Dekati ELPI Multi-l light scattering : Envirometrix

14 Sampling & measurement issues Aerosol is sub-micron cross-over region for choice of optimal techniques Aerosol is semi-volatile minimise dilution awareness of condensation drop-out Aerosol is concentrated minimise transit time to minimise coagulation Aerosol is transient and dynamic (2-3s puff) appropriate time resolution for instrument of choice Cambustion DMS-500 generally preferred choice for cigarette smoke Malvern Spraytec generally preferred choice for THP/ e-cigarettes

15 Particle / droplet diameter Product 3R4F Ref Cigarette glo THP ifuse Hybrid TP Vype epen2 Mobility MMD (nm) 272 ± ± GSD 1.42 ± ± Vype Pebble Optical Dv 50 (nm) ± ± ± ± 90 GSD ± ± ± ± 0.16 Cigarettes / glo smoked to 55/2/30; others to 55/3/30

16 Measurement summary Data for novel device aerosols are broadly similar at approx. 600 nm (optical) Larger than cigarette smoke, but sub-micron and respirable Higher humectant (e.g. glycerol) in novel device formulations more likely to show evaporative losses with DMS-500, where operation is at reduced pressure Geometric standard deviations consistent with other condensation aerosols

17 Summary Increasing number of nicotine delivery platforms / devices worldwide with significant consumer demand Principal mode of aerosol generation remains condensation aerosols Aerosols physically similar that is, respirable Aerosols chemically diverse lower heating modes reduce complexity and toxicant formation Regulatory landscape varies widely Many potential issues can be addressed by appropriate product stewardship, including design, materials, emissions testing, in vitro toxicology testing, in-use studies Longer timescale required to fully address individual and population risk assessment As aerosol scientists we should be contributing to scientific understanding of emerging issues and risk assessment

18 Thank you

Aerosol Characterisation of e-cigarettes. Ross Cabot, Anna Koc, Caner U. Yurteri & John McAughey

Aerosol Characterisation of e-cigarettes. Ross Cabot, Anna Koc, Caner U. Yurteri & John McAughey Aerosol Characterisation of e-cigarettes Ross Cabot, Anna Koc, Caner U. Yurteri & John McAughey European Aerosol Conference, Prague 2-6 September 2013 1 Organisation Background Description History Regulation

More information

The concept that not all tobacco and nicotine products

The concept that not all tobacco and nicotine products A Model Risk Continuum for Tobacco and Nicotine Products by Chris Proctor, Sudhanshu Patwardhan, and James Murphy The concept that not all tobacco and nicotine products present the same risks to human

More information

RNA-SEQ based toxicogenomics comparison of airway cells exposed to Vype TM epen vapour and cigarette smoke.

RNA-SEQ based toxicogenomics comparison of airway cells exposed to Vype TM epen vapour and cigarette smoke. RNA-SEQ based toxicogenomics comparison of airway cells exposed to Vype TM epen vapour and cigarette smoke Emmanuel Minet, PhD CBTOX 2017, Goiânia emmanuel_minet@bat.com CONFLICT OF INTEREST STATEMENT

More information

UK E-Cigarette Summit Relative risks of cancer posed by combustible and vapourising forms of nicotine delivery: Evidence from chemical exposures

UK E-Cigarette Summit Relative risks of cancer posed by combustible and vapourising forms of nicotine delivery: Evidence from chemical exposures UK E-Cigarette Summit 2017 Relative risks of cancer posed by combustible and vapourising forms of nicotine delivery: Evidence from chemical exposures Ed Stephens University of St Andrews Scope of presentation

More information

A proposed bridging approach for the assessment of novel tobacco products

A proposed bridging approach for the assessment of novel tobacco products A proposed bridging approach for the assessment of novel tobacco products Dr. Ian M. Fearon British American Tobacco (Investments) Limited R&D Centre Southampton, U.K. Agenda Insight into BAT R&D Evolution

More information

Effect of Sugars on Selected Toxicant Yields in e-cigarettes

Effect of Sugars on Selected Toxicant Yields in e-cigarettes CORESTA Congress, 11th October 2016, Berlin Effect of Sugars on Selected Toxicant Yields in e-cigarettes Jennifer Margham 1, Kevin McAdam 1 ST 31 BERLIN 2016 1 British American Tobacco, Group R&D, Southampton,

More information

Modelling the effects of user exposure to harmful emissions across the spectrum of nicotine delivery

Modelling the effects of user exposure to harmful emissions across the spectrum of nicotine delivery Global Nicotine Forum 2018 Modelling the effects of user exposure to harmful emissions across the spectrum of nicotine delivery Ed Stephens University of St Andrews Declaration: No conflicts of interest

More information

The Chemical characterisation of E-device Aerosols

The Chemical characterisation of E-device Aerosols The Chemical characterisation of E-device Aerosols Stuart Martin & Chris Rawlinson CORESTA SSPT ST02 30 th September 2013 Group R&D, British American Tobacco, Southampton, UK Introduction BAT s initial

More information

Electronic cigarettes: Pre-clinical and clinical assessment

Electronic cigarettes: Pre-clinical and clinical assessment Disclaimer: The information in these materials is a formal dissemination of information by BAT and issues discussed in my presentation are not in any official manner related to/voiced by EUROTOX or its

More information

E-cigarette consumption and puffing topography data. Dr Sudhanshu Patwardhan FDA CTP Workshop, Hyattsville, Maryland. March 9, 2015.

E-cigarette consumption and puffing topography data. Dr Sudhanshu Patwardhan FDA CTP Workshop, Hyattsville, Maryland. March 9, 2015. E-cigarette consumption and puffing topography data Dr Sudhanshu Patwardhan FDA CTP Workshop, Hyattsville, Maryland. March 9, 2015. Outline Nicoventures Introduction Topography and use patterns to inform

More information

Next Generation Products Sandra Costigan, Marianna Gaca, ChuanLiu, Kevin McAdam, James J. Murphyand Christopher Proctor British American Tobacco 21

Next Generation Products Sandra Costigan, Marianna Gaca, ChuanLiu, Kevin McAdam, James J. Murphyand Christopher Proctor British American Tobacco 21 Next Generation Products Sandra Costigan, Marianna Gaca, ChuanLiu, Kevin McAdam, James J. Murphyand Christopher Proctor British American Tobacco 21 st October 2015 Contents Evolution of products across

More information

Nicotine delivery from e-cigarettes part I: study designs for two pharmacokinetic studies.

Nicotine delivery from e-cigarettes part I: study designs for two pharmacokinetic studies. LOS ANGELES CLINICAL TRIALS Nicotine delivery from e-cigarettes part I: study designs for two pharmacokinetic studies. Ian M. Fearon, Alison Eldridge, Nathan Gale, Christopher J. Shepperd, Mike McEwan,

More information

Assessment of the Tobacco Heating System (THS) 2.2, A Candidate Modified Risk Tobacco Product: From Concept to Early Clinical Data

Assessment of the Tobacco Heating System (THS) 2.2, A Candidate Modified Risk Tobacco Product: From Concept to Early Clinical Data Assessment of the Tobacco Heating System (THS) 2.2, A Candidate Modified Risk Tobacco Product: From Concept to Early Clinical Data Global Forum on Nicotine 2015 Bruce D. Clark PhD Philip Morris International

More information

Particle Size Distribution of E-Cigarette Aerosols and the Relationship to Cambridge Filter Pad Collection Efficiency

Particle Size Distribution of E-Cigarette Aerosols and the Relationship to Cambridge Filter Pad Collection Efficiency Particle Size Distribution of E-Cigarette Aerosols and the Relationship to Cambridge Filter Pad Collection Efficiency S.L Alderman, C. Song, S. Moldoveanu, S.K. Cole R.J. Reynolds Tobacco Company, Winston-Salem,

More information

The adverse health effects associated with traditional

The adverse health effects associated with traditional APPLIED IN VITRO TOXICOLOGY Volume 4, Number 2, 2018 Mary Ann Liebert, Inc. DOI: 10.1089/aivt.2018.0001 Characterization of a Vitrocell VC1 Using Nicotine Dosimetry: An Essential Component Toward Standardized

More information

00:08 For decades our scientists have endeavoured to reduce the risks of tobacco use and continue to do so today. 00:15

00:08 For decades our scientists have endeavoured to reduce the risks of tobacco use and continue to do so today. 00:15 00:00 British American Tobacco 00:02 00:03 The Electronic Cigarette 00:07 00:08 For decades our scientists have endeavoured to reduce the risks of tobacco use and continue to do so today. 00:15 00:15 Our

More information

E-Cigarette Product Regulation and Standardisation

E-Cigarette Product Regulation and Standardisation E-Cigarette Product Regulation and Standardisation Derek Mariner British American Tobacco, Research & Development, Southampton UK E-cigarette Workshop, Paper STW03 CORESTA Smoke Science and Product Technology

More information

Understanding Regulatory Global Requirements for Nasal Drug Products. Julie D. Suman, Ph.D. April 8, 2016

Understanding Regulatory Global Requirements for Nasal Drug Products. Julie D. Suman, Ph.D. April 8, 2016 Understanding Regulatory Global Requirements for Nasal Drug Products Julie D. Suman, Ph.D. April 8, 2016 AGENDA NDA vs ANDA Regulatory Approaches for Bioequivalence (BE) FDA Drug Specific Guidances FDA,

More information

Development and validation of a device for measuring puffing topography of e-cigarette users

Development and validation of a device for measuring puffing topography of e-cigarette users Development and validation of a device for measuring puffing topography of e-cigarette users CUNNINGHAM A. 1 ; SLAYFORD S. 1 ; VAS C. 1 ; GEE J. 1 ; COSTIGAN S. 2 ; PRASAD K. 1 1 British American Tobacco,

More information

What is combustion and why is the absence of combustion important for heat not burn products

What is combustion and why is the absence of combustion important for heat not burn products What is combustion and why is the absence of combustion important for heat not burn products Global Forum on Nicotine 2017 June 16 th 2017 Thomas Mc Grath PhD PMI R&D, Philip Morris Products S.A., Quai

More information

Application of dosimetry tools for the assessment of e cigarette aerosol and cigarette smoke generated on two different in vitro exposure systems

Application of dosimetry tools for the assessment of e cigarette aerosol and cigarette smoke generated on two different in vitro exposure systems DOI 10.1186/s13065-016-0221-9 RESEARCH ARTICLE Open Access Application of dosimetry tools for the assessment of e cigarette aerosol and cigarette smoke generated on two different in vitro exposure systems

More information

Key Variables in Assessing ENDS Devices AND WHY THAT ISN T VOLTS

Key Variables in Assessing ENDS Devices AND WHY THAT ISN T VOLTS Key Variables in Assessing ENDS Devices AND WHY THAT ISN T VOLTS About Evolv and John Bellinger Evolv is the largest domestic manufacturer of ENDS control circuitry Founded 2010, located in Hudson, OH

More information

BRITISH AMERICAN TOBACCO Science & Technology report

BRITISH AMERICAN TOBACCO Science & Technology report BRITISH AMERICAN TOBACCO Science & Technology 2015 report Foreword 1 Dr David O Reilly, Group Scientific and R&D Director RESEARCH PRIORITIES Stewardship and next generation products 2 Dr Christopher Proctor

More information

Heat-not-Burn Products: Scientific Assessment of Risk Reduction

Heat-not-Burn Products: Scientific Assessment of Risk Reduction Heat-not-Burn Products: Scientific Assessment of Risk Reduction Tobacco Merchants Association 2015 Annual Meeting Moira Gilchrist PhD Philip Morris International R&D May 20th 2015 The Objective is Harm

More information

The importance of offering adult smokers a portfolio of potentially less harmful products

The importance of offering adult smokers a portfolio of potentially less harmful products The importance of offering adult smokers a portfolio of potentially less harmful products International Symposium on Nicotine Technology June 15 th 2017 Thomas Mc Grath, PhD PMI R&D, Philip Morris Products

More information

E-Cigarette Update: Secondhand Vapour

E-Cigarette Update: Secondhand Vapour E-Cigarette Update: Secondhand Vapour Toxicity and Health Effects The popularity of e-cigarettes continues to increase, with more Canadians than ever using them indoors and out. The scientific evidence

More information

OPTIMISING ANALYTICAL STRATEGIES FOR THE DEMONSTRATION OF BIOEQUIVALENCE IN A GENERIC NEBULISER

OPTIMISING ANALYTICAL STRATEGIES FOR THE DEMONSTRATION OF BIOEQUIVALENCE IN A GENERIC NEBULISER OPTIMISING ANALYTICAL STRATEGIES FOR THE DEMONSTRATION OF BIOEQUIVALENCE IN A GENERIC NEBULISER US FDA guidance for the in vitro demonstration of bioequivalence in a generic nebuliser directly references

More information

S.C. Moldoveanu, A.G. Hudson, A. Harrison. R.J. Reynolds Tobacco Co.

S.C. Moldoveanu, A.G. Hudson, A. Harrison. R.J. Reynolds Tobacco Co. The Determination of Diacetyl and Acetylpropionyl in Aerosols from Electronic Smoking Devices using Gas Chromatography Triple Quad Mass Spectrometry S.C. Moldoveanu, A.G. Hudson, A. Harrison R.J. Reynolds

More information

Cardiovascular effects of nicotine vs. cigarette smoke

Cardiovascular effects of nicotine vs. cigarette smoke Cardiovascular effects of nicotine vs. cigarette smoke Dr Konstantinos Farsalinos Researcher Onassis Cardiac Surgery Center, Greece University of Patras, Greece National School of Public Health, Athens-Greece

More information

Pierre-Marie GUITTON Next Generation Nicotine Delivery London June, 2017

Pierre-Marie GUITTON Next Generation Nicotine Delivery London June, 2017 Contribution To Develop Standards For The Global Vapour Industry Pierre-Marie GUITTON Next Generation Nicotine Delivery London - 14-15 June, 2017 Outline Introduction to CORESTA CORESTA activities Process

More information

The Effect of Puff Profile and Volume on the Yields of E-Cigarettes

The Effect of Puff Profile and Volume on the Yields of E-Cigarettes The Effect of Puff Profile and Volume on the Yields of E-Cigarettes Dr M J Taylor, Filtrona Technology Centre Smoke Science/Product Technology Meeting Seville, Spain, 29 September to 03 October 2013 Introduction

More information

A study to examine changes in exposure to cigarette smoke chemicals when a smoker switches to using a tobacco heating product. Part I: Study Design.

A study to examine changes in exposure to cigarette smoke chemicals when a smoker switches to using a tobacco heating product. Part I: Study Design. A study to examine changes in exposure to cigarette smoke chemicals when a smoker switches to using a tobacco heating product. Part I: Study Design. Nathan Gale 1, Mike McEwan 1, Alison Eldridge 1, Neil

More information

Responsible Practice in E-Vapour Products (EVP) Product Stewardship

Responsible Practice in E-Vapour Products (EVP) Product Stewardship Responsible Practice in E-Vapour Products (EVP) Product Stewardship Tanvir Walele, MSc, ERT 11 October 2016 1 Responsible Practice Responsible practice can be divided in to 3 areas: Pre-market product

More information

Regulatory Support for Tobacco Products. Feeling daunted by the regulatory process for tobacco products? Don t worry Battelle can help.

Regulatory Support for Tobacco Products. Feeling daunted by the regulatory process for tobacco products? Don t worry Battelle can help. Regulatory Support for Tobacco Products Feeling daunted by the regulatory process for tobacco products? Don t worry Battelle can help. PREMARKET TOBACCO (PMTA) HUMAN FACTORS STUDIES SUBSTANTIAL EQUIVALENCE

More information

RE: Docket No. FDA-2014-N , Electronic Cigarettes and the Public Health

RE: Docket No. FDA-2014-N , Electronic Cigarettes and the Public Health VIA ELECTRONIC SUBMISSION June 30, 2015 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 RE: Docket No. FDA-2014-N-1936-0001, Electronic

More information

Nicotine delivery from e-cigarettes part II: data and learnings from two pharmacokinetic studies.

Nicotine delivery from e-cigarettes part II: data and learnings from two pharmacokinetic studies. LOS ANGELES CLINICAL TRIALS Nicotine delivery from e-cigarettes part II: data and learnings from two pharmacokinetic studies. Ian M. Fearon, Alison Eldridge, Nathan Gale, Christopher J. Shepperd, Mike

More information

Contribution To Standards Development For Next Generation Products. Eduardo BEREA Alternative Ingredients ENDS 2018 London 4-5 June 2018

Contribution To Standards Development For Next Generation Products. Eduardo BEREA Alternative Ingredients ENDS 2018 London 4-5 June 2018 Contribution To Standards Development For Next Generation Products Eduardo BEREA Alternative Ingredients ENDS 2018 London 4-5 June 2018 2010s Disposables / Cigalikes Rechargeable Cigalike & Cartomizers

More information

Tobacco Heating System 2.2, A Candidate Modified Risk Tobacco Product: Cardiovascular Disease Risk Assessment

Tobacco Heating System 2.2, A Candidate Modified Risk Tobacco Product: Cardiovascular Disease Risk Assessment Tobacco Heating System 2.2, A Candidate Modified Risk Tobacco Product: Cardiovascular Disease Risk Assessment Global Forum on Nicotine 2016 Moira Gilchrist PhD Philip Morris International R&D June 17th

More information

A combination of licensed medication and professional support is four times more likely to achieve a stop in smoking behaviour.

A combination of licensed medication and professional support is four times more likely to achieve a stop in smoking behaviour. PHA Position Statement E-cigarettes 30 May 2014 The Public Health Agency (PHA) considers E-cigarettes with caution at this time. E-cigarettes are not licensed nicotine replacement products. They are not

More information

Cooperation Centre for Scientific Research Relative to Tobacco. CORESTA Guide N 22

Cooperation Centre for Scientific Research Relative to Tobacco. CORESTA Guide N 22 Cooperation Centre for Scientific Research Relative to Tobacco CORESTA Guide N 22 Technical Guide for the Selection of Appropriate Intense Vaping Regimes for E-Vapour Devices February 2018 E-Vapour Sub-Group

More information

E-Cigarettes: Current Perspective

E-Cigarettes: Current Perspective E-Cigarettes: Current Perspective Aruni Bhatnagar, Ph.D. Professor of Medicine University of Louisville Louisville, KY Electronic Cigarettes E-cigarettes are electronic nicotine delivery systems (ENDS),

More information

Analysis of Chemical Components from High, Med & Low Nicotine Cartridges

Analysis of Chemical Components from High, Med & Low Nicotine Cartridges Analysis of Chemical Components from High, Med & Low s Report Number: D318 Cara Valance & Mike Ellicott 10 September 2008 LPD Laboratory Services Blackburn MicroTech Solutions Ltd. Philips Road Blackburn

More information

Might Smoking Rates go up in Flames? Dr John Schoonbee, Chief Medical Officer, Swiss Re

Might Smoking Rates go up in Flames? Dr John Schoonbee, Chief Medical Officer, Swiss Re Might Smoking Rates go up in Flames? Dr John Schoonbee, Chief Medical Officer, Swiss Re 2 Agenda Smoking is still a problem Stopping is hard Electronic cigarettes Reduced Risk tobacco products Males >15yr

More information

Applicant Name: GD Sigelei Electroinc Tech Co., Ltd B7 Building, No.1 District, Xicheng Science and Technology Park, Hengli Town, Dongguan, China

Applicant Name: GD Sigelei Electroinc Tech Co., Ltd B7 Building, No.1 District, Xicheng Science and Technology Park, Hengli Town, Dongguan, China Date: Jan.17, 2018 Applicant Name: GD Sigelei Electroinc Tech Co., Ltd Applicant Add.: B7 Building, No.1 District, Xicheng Science and Technology Park, Hengli Town, Dongguan, China Test sample(s) was(were)

More information

Understanding cascade impaction and its importance for inhaler testing

Understanding cascade impaction and its importance for inhaler testing Understanding cascade impaction and its importance for inhaler testing Mark Copley, Technical Sales Manager Inhalation product development is an important area of activity for the pharmaceutical sector.

More information

2014_TSRC77_Melton.pdf

2014_TSRC77_Melton.pdf Determination of Selected Flavour, Humectant and Plasticizer compounds in Tobacco, Tobacco Products, Electronic Cigarette Liquid and Electronic Cigarette Vapour by Gas Chromatography with Mass Selective

More information

CORESTA Recommended Methods with history and correspondence with ISO Standards

CORESTA Recommended Methods with history and correspondence with ISO Standards CORESTA Recommended with histy and crespondence with Standards DISCLAIMER: This table is made available f the convenience of tobacco researchers and is f infmation purposes only. The precise crelation

More information

Cigarette Smoke Generator

Cigarette Smoke Generator Sophisticated Life Science Research Instrumentation Cigarette Smoke Generator For Inhalation and Analytic Studies Info@TSE-Systems.com Contents Cigarette Smoke Generator Fully Automatic 3 Sensors 3 Cigarette

More information

Adapting Pharmacopeial Testing for Pharmaceutical Equivalence Studies. Julie D. Suman, Ph.D. March 29, 2016

Adapting Pharmacopeial Testing for Pharmaceutical Equivalence Studies. Julie D. Suman, Ph.D. March 29, 2016 Adapting Pharmacopeial Testing for Pharmaceutical Equivalence Studies Julie D. Suman, Ph.D. March 29, 2016 AGENDA Regulatory Approaches for Bioequivalence (BE) Compendial Testing Vs Pharmaceutical Equivalence

More information

Contribution To Standards Development For Next Generation Products. Dr Nils ROSE

Contribution To Standards Development For Next Generation Products. Dr Nils ROSE Contribution To Standards Development For Next Generation Products Dr Nils ROSE 2010s Disposables / Cigalikes Rechargeable Cigalike & Cartomizers Fixed Voltage Devices Drip Tips Open System Atomizer Single

More information

ZYBAX AIR MATERIAL SAFETY DATA SHEET

ZYBAX AIR MATERIAL SAFETY DATA SHEET ZYBAX AIR MATERIAL SAFETY DATA SHEET Date of issue 28/05/2015 eco-friendly odour removal For more information visit www.zybax.co.uk 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING

More information

Dynamic properties of exhaled e-cigarette aerosol vs. conventional cigarette smoke

Dynamic properties of exhaled e-cigarette aerosol vs. conventional cigarette smoke Willkommen Welcome Bienvenue Dynamic properties of exhaled e-cigarette aerosol vs. conventional cigarette smoke Ari Setyan 1,2, Tadas Prasauskas 3, Dainius Martuzevicius 3, Grant O Connell 4, Xavier Cahours

More information

Effects of viscosity, pump mechanism and nozzle geometry on nasal spray droplet size

Effects of viscosity, pump mechanism and nozzle geometry on nasal spray droplet size ILASS Europe 21, 23rd Annual Conference on Liquid Atomization and Spray Systems, Brno, Czech Republic, September 21 P. Kippax 1, J. Suman 2, A. Virden 1* and G. Williams 3 1 Malvern Instruments, Grovewood

More information

Electronic Cigarettes, Nicotine and Policy Implications

Electronic Cigarettes, Nicotine and Policy Implications Electronic Cigarettes, Nicotine and Policy Implications Neal L Benowitz MD University of California San Francisco The E-Cigarette Summit The Royal Society London November 17, 2016 Disclosures Dr Benowitz

More information

RISK FROM E-VAPOUR PRODUCTS FOR USERS AND BYSTANDERS

RISK FROM E-VAPOUR PRODUCTS FOR USERS AND BYSTANDERS RISK FROM E-VAPOUR PRODUCTS FOR USERS AND BYSTANDERS Dr Konstantinos Farsalinos Researcher Onassis Cardiac Surgery Center, Greece University of Patras, Greece COI Past 36 months 1 study funded by non-profit

More information

The effect of active and passive smoking on inhaled drugs in respiratory patients

The effect of active and passive smoking on inhaled drugs in respiratory patients CHAPTER 12 The effect of active and passive smoking on inhaled drugs in respiratory patients G. Invernizzi*, A. Ruprecht*, P. Paredi #, R. Mazza*, C. De Marco*, R. Boffi* *Tobacco Control Unit, National

More information

GC-MS analysis of e-liquids taken. from e-cigarettes and e-liquids (e-juice) before use in e-cigarettes

GC-MS analysis of e-liquids taken. from e-cigarettes and e-liquids (e-juice) before use in e-cigarettes GC-MS analysis of e-liquids taken from e-cigarettes and e-liquids (e-juice) before use in e-cigarettes John H. Lauterbach, Ph.D., DABT Lauterbach & Associates, LLC, Macon, GA 31210-4708 USA Deborah A.

More information

SUPER SMOKER EXPERT REPORT FINAL REPORT

SUPER SMOKER EXPERT REPORT FINAL REPORT TOXICOLOGY LABORATORY GASTHUISBERG CAMPUS, O&N2 P8 922, HERESTRAAT 49 D-3000 LEUVEN CATHOLIC UNIVERSITY LEUVEN LEUVEN, 29 June 2007 SUPER SMOKER EXPERT REPORT FINAL REPORT On 28 February 2007 the following

More information

Nonclinical Safety Evaluation of Inhalation Drug Products

Nonclinical Safety Evaluation of Inhalation Drug Products Nonclinical Safety Evaluation of Inhalation Drug Products February 13, 2002 Life Science Research Organization Bethesda, Maryland Luqi Pei, Ph.D. Division of Pulmonary and Allergy Drug Products Center

More information

DISSOLUTION TESTING - Exploring the Link Between Particle Size & Dissolution Behavior for OINDPs

DISSOLUTION TESTING - Exploring the Link Between Particle Size & Dissolution Behavior for OINDPs Issue: March 2016, Posted Date: 3/1/2016 DISSOLUTION TESTING - Exploring the Link Between Particle Size & Dissolution Behavior for OINDPs INTRODUCTION In the development of orally inhaled and nasal products

More information

DEVELOPMENT OF A TECHNIQUE FOR THE DETERMINATION OF ph-values OF AEROSOLS GENERATED BY E-CIGARETTES

DEVELOPMENT OF A TECHNIQUE FOR THE DETERMINATION OF ph-values OF AEROSOLS GENERATED BY E-CIGARETTES DEVELOPMENT OF A TECHNIQUE FOR THE DETERMINATION OF ph-values OF AEROSOLS GENERATED BY E-CIGARETTES John H. Lauterbach, Ph.D., DABT Lauterbach & Associates, LLC Macon, GA 31210-4708 USA Outline for presentation

More information

Air Quality assessment during indoor use of the Tobacco Heating System 2.2

Air Quality assessment during indoor use of the Tobacco Heating System 2.2 Air Quality assessment during indoor use of the Tobacco Heating System 2.2 THS 2.2. is commercialized under the IQOS brand name Dr Catherine Goujon Ginglinger - Philip Morris International Research & Development,

More information

Measuring Emissions as Part of a Regulatory Regime. Prof. Riccardo Polosa Professor of Internal Medicine and Convenor CEN TC437/WG4

Measuring Emissions as Part of a Regulatory Regime. Prof. Riccardo Polosa Professor of Internal Medicine and Convenor CEN TC437/WG4 Measuring Emissions as Part of a Regulatory Regime Prof. Riccardo Polosa Professor of Internal Medicine and Convenor CEN TC437/WG4 . (b) a list of all ingredients contained in, and emissions resulting

More information

DR. MARIANNA D GACA Manager, Pre-Clinical Assessment R&D, British American Tobacco

DR. MARIANNA D GACA Manager, Pre-Clinical Assessment R&D, British American Tobacco National Academy of Sciences, Engineering and Medicine Washington 21st February 2017 Pre-clinical and clinical testing of ENDS: Results from in vitro assays DR. MARIANNA D GACA Manager, Pre-Clinical Assessment

More information

T U R B I S C A N. Automatic stability analyses for pharmaceutics

T U R B I S C A N. Automatic stability analyses for pharmaceutics Automatic stability analyses for pharmaceutics Stability of pharmaceutics o Pharmaceutical formulations suspension (eye drops, drug powder, ) emulsion (cream, lotion, parenteral emulsion, ) aerosol (pmdi,

More information

Thresholds of Toxicological Concern

Thresholds of Toxicological Concern Thresholds of Toxicological Concern Introduction to the Concept Heli M Hollnagel (hmhollnagel@dow.com) Next 20 Minutes TTC Databases Grouping schemes Risk assessment approach What is excluded from TTC

More information

PROCEDURE FOR GENERATION AND TESTING OF MAINSTREAM TOBACCO HEATING SYSTEM (THS or IQOS) AEROSOL USING A LINEAR SMOKING MACHINE

PROCEDURE FOR GENERATION AND TESTING OF MAINSTREAM TOBACCO HEATING SYSTEM (THS or IQOS) AEROSOL USING A LINEAR SMOKING MACHINE PROCEDURE FOR GENERATION AND TESTING OF MAINSTREAM TOBACCO HEATING SYSTEM (THS or IQOS) AEROSOL USING A LINEAR SMOKING MACHINE 1 P age Table of contents / Table des matières 1 Introduction...3 1 Scope...3

More information

Smoking, e-cigs and reduced risk products. Dr John Schoonbee, IMS November 2017

Smoking, e-cigs and reduced risk products. Dr John Schoonbee, IMS November 2017 Smoking, e-cigs and reduced risk products Dr John Schoonbee, IMS November 2017 2 The storyline smoking is bad yet many folks still smoke because quitting is very hard is it better, if one cannot quit,

More information

A New USP Tool The Class Monograph

A New USP Tool The Class Monograph CHPA Regulatory, Scientific & Quality Conference Washington DC, May 13, 2014 Quality Session 4 A New USP Tool The Class Monograph Alan R. Potts, Ph.D. Principal Scientific Liaison-Chemical Medicines The

More information

TEST REPORT. Mutagenic effect of tobacco smoke in comparison to the vapour of two e-liquids manufactured by Happy People GmbH

TEST REPORT. Mutagenic effect of tobacco smoke in comparison to the vapour of two e-liquids manufactured by Happy People GmbH Page 1 (6) Dartsch Scientific GmbH Oskar-von-Miller-Str. 10 D-86956 Schongau Firma Happy People GmbH Lindwurmstr. 5 80337 München Oskar-von-Miller-Straße 10 D-86956 Schongau, Germany Fon Diessen: +49 8807

More information

Bill. amending the Tobacco Control Act, No. 6/2002, with subsequent amendments. From the Minister of Health.

Bill. amending the Tobacco Control Act, No. 6/2002, with subsequent amendments. From the Minister of Health. 146 th Legislative session, 2016 2017. Parliamentary document x x. matter. Government bill. Bill amending the Tobacco Control Act, No. 6/2002, with subsequent amendments. From the Minister of Health. Article

More information

Reports of advisory bodies

Reports of advisory bodies EXECUTIVE BOARD 142nd session 27 November 2017 Provisional agenda item 6.3 Reports of advisory bodies Expert committees and study groups 1 Report by the Director-General EVALUATION OF CERTAIN CONTAMINANTS

More information

Animal testing versus calculation method

Animal testing versus calculation method Animal testing versus calculation method Dr. Tamara Coja, MSc Toxicology Institute for Plant Protection Products, Department for Toxicology Interzonal workshop Harmonisation of risk assessment in section

More information

ONLINE AEROSOL ANALYSIS USING FTIR: ASSESSING CARBONYL YIELDS IN E-CIGARETTE AEROSOL

ONLINE AEROSOL ANALYSIS USING FTIR: ASSESSING CARBONYL YIELDS IN E-CIGARETTE AEROSOL ONLINE AEROSOL ANALYSIS USING FTIR: ASSESSING CARBONYL YIELDS IN E-CIGARETTE AEROSOL 27.Aug- 1.Sep 217 European Aerosol Conference 217 Zürich, Switzerland Falk Radtke PMI R&D, Philip Morris Products S.A.,

More information

SAFETY DATA SHEET. SECTION 1: Identification of the substance/mixture and of the company/undertaking

SAFETY DATA SHEET. SECTION 1: Identification of the substance/mixture and of the company/undertaking SAFETY DATA SHEET SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Trade name or designation of the mixture Registration number - Synonyms Product

More information

Reduced-Risk Products Science Update

Reduced-Risk Products Science Update Reduced-Risk Products Science Update Dr. Ian Jones, PhD JTI VP, Reduced-Risk Products Science Forward-Looking Statements This presentation contains forward-looking statements. These statements appear in

More information

Thermal Degradation Studies of Electronic Cigarette Liquids Part 2: Development of a Model Reaction System Used to Study α-dicarbonyl Formation

Thermal Degradation Studies of Electronic Cigarette Liquids Part 2: Development of a Model Reaction System Used to Study α-dicarbonyl Formation Thermal Degradation Studies of Electronic Cigarette Liquids Part 2: Development of a Model Reaction System Used to Study α-dicarbonyl Formation Melvin, M.S.; Avery, K.C.; Ballentine, R.M.; Gardner, W.P.;

More information

SECTION 1: Identification of the substance/mixture and of the company/undertaking

SECTION 1: Identification of the substance/mixture and of the company/undertaking SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier 1.2. Relevant identified uses of the substance or mixture and uses advised against Use of the substance/mixture

More information

Chromatographic Profiling as a Tool in the Comparison and Evaluation of Complex Mixtures

Chromatographic Profiling as a Tool in the Comparison and Evaluation of Complex Mixtures Chromatographic Profiling as a Tool in the Comparison and Evaluation of Complex Mixtures James C. Rogers*, Lisa S. Winkler, and Michael F. Borgerding R.J. Reynolds Tobacco Company, Research and Development,

More information

SAFETY DATA SHEET (Globally Harmonized System)

SAFETY DATA SHEET (Globally Harmonized System) SAFETY DATA SHEET (Globally Harmonized System) SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1 Product identifier BIO-MOS OA 1.2 Other means of identification 1.3

More information

COMPARISON OF RESULTS FROM THREE TECHNIQUES FOR THE ESTIMATION OF E-LIQUID ph-values

COMPARISON OF RESULTS FROM THREE TECHNIQUES FOR THE ESTIMATION OF E-LIQUID ph-values COMPARISON OF RESULTS FROM THREE TECHNIQUES FOR THE ESTIMATION OF E-LIQUID ph-values J.H. Lauterbach, Ph.D., DABT Lauterbach & Associates, LLC Macon, GA 31210-4708 Quotations from Pagano et al., 2016 E-Cigs

More information

Advanced in vitro exposure systems

Advanced in vitro exposure systems Advanced in vitro exposure systems VITROCELL VC 1/7 SMOKING MACHINE Features for e-cigarettes VITROCELL VC 1/7 SMOKING MACHINE Linear smoking machine with high tech features square puff profiles higher

More information

E-Vapour (EVAP) Sub-Group 2017 Report. Kitzbühel, Austria October 10, 2017

E-Vapour (EVAP) Sub-Group 2017 Report. Kitzbühel, Austria October 10, 2017 E-Vapour (EVAP) Sub-Group 2017 Report Kitzbühel, Austria October 10, 2017 History Evolution o 2014, formation of E-cigarette TF o 2016, TF activities completed; formation of E-vapor product SG 2 E-Vapour

More information

ESPs are battery-operated devices that contain cartridges filled with liquid chemicals. The chemicals turn into a vapour that the user inhales (this

ESPs are battery-operated devices that contain cartridges filled with liquid chemicals. The chemicals turn into a vapour that the user inhales (this ESPs are battery-operated devices that contain cartridges filled with liquid chemicals. The chemicals turn into a vapour that the user inhales (this is called vaping). They do not contain tobacco. They

More information

SACTob Position Statement on Nicotine and Its Regulation in Tobacco and Non-Tobacco Products.

SACTob Position Statement on Nicotine and Its Regulation in Tobacco and Non-Tobacco Products. SACTob Position Statement on Nicotine and Its Regulation in Tobacco and Non-Tobacco Products. Background Over the past two decades a wealth of research findings have pointed to nicotine as the key pharmacological

More information

Safety Data Sheet Product No Cresyl (Fast) Violet, Certified Issue Date ( ) Review Date ( )

Safety Data Sheet Product No Cresyl (Fast) Violet, Certified Issue Date ( ) Review Date ( ) Safety Data Sheet Product No. 18709 Cresyl (Fast) Violet, Certified Issue Date (01-15-13) Review Date (01-16-15) Section 1: Product and Company Identification Product Name: Cresyl (Fast) Violet, Certified

More information

Air Quality assessment during indoor use of the Tobacco Heating System 2.2

Air Quality assessment during indoor use of the Tobacco Heating System 2.2 Air Quality assessment during indoor use of the Tobacco Heating System 2.2 THS 2.2. is commercialized under the IQOS brand name Maya Mitova, Catherine Goujon Ginglinger, Michel Rotach, Serge Maeder Philip

More information

How to test medical devices as families? Dr. Sophie Michel Study Director Medical Devices Toxikon Europe

How to test medical devices as families? Dr. Sophie Michel Study Director Medical Devices Toxikon Europe How to test medical devices as families? Dr. Sophie Michel Study Director Medical Devices Toxikon Europe Introduction Category Body Contact Contact Contact duration Cytotoxicity Sensitivity/Sensitization

More information

E-cigarette reforms. Supplement to the Tobacco retailer guide about reforms commencing 1 August 2017

E-cigarette reforms. Supplement to the Tobacco retailer guide about reforms commencing 1 August 2017 E-cigarette reforms Supplement to the Tobacco retailer guide about reforms commencing 1 August 2017 E-cigarette reforms: supplement to the Tobacco retailer guide Page 1 E-cigarette reforms Supplement

More information

Material Safety Data Sheet

Material Safety Data Sheet Material Safety Data Sheet 1. Reagent / Product and Company Identification Product name: Salmonella Agglutinating Serum Product code: PL6000-6041 and PL6100 6157 PL6600 PL6678 Use/description of product:

More information

CHARACTERIZATION OF PUFF TOPOGRAPHY DURING 8- HOURS OF AD LIBITUM USE OF MARKTEN E-VAPOR PRODUCTS

CHARACTERIZATION OF PUFF TOPOGRAPHY DURING 8- HOURS OF AD LIBITUM USE OF MARKTEN E-VAPOR PRODUCTS CHARACTERIZATION OF PUFF TOPOGRAPHY DURING 8- HOURS OF AD LIBITUM USE OF MARKTEN E-VAPOR PRODUCTS Jeffery Edmiston, Qiwei Liang, Andrea Vansickel, Jianmin Liu, Yuxi Zhao, Mohamadi Sarkar Altria Client

More information

TNCO Testing procedures

TNCO Testing procedures TNCO Testing procedures Chris Proctor Pete Davis British American Tobacco Group R&D UK US FDA Center for Tobacco Products Scientific Workshop 30-31 July 2013 1 A. Describe the different extraction steps

More information

Presented at FDLI Annual Conference, Washington DC, May 4, 2017, 10:45 to 11:30am 1

Presented at FDLI Annual Conference, Washington DC, May 4, 2017, 10:45 to 11:30am 1 Vice President, Research, Health Policy and Abuse Liability Pinney Associates And Professor, Adjunct, Behavioral Biology Department of Psychiatry and Behavioral Sciences The Johns Hopkins University School

More information

Eco Clear Shield - Polycarbonate

Eco Clear Shield - Polycarbonate SAFETY DATA SHEET Eco Clear Shield - Polycarbonate NON-Hazardous Substance, NON-Dangerous Goods Section 1: Identification 1.1 Product Identifier Polycarbonate coating Trade name : Eco Clear Shield - Polycarbonate

More information

What are ESD s & Why are Youth VAPING?? Jen Valera Hawai i Island Coalition Assistant Hawaiʻi Public Health Institute

What are ESD s & Why are Youth VAPING?? Jen Valera Hawai i Island Coalition Assistant Hawaiʻi Public Health Institute What are ESD s & Why are Youth VAPING?? Jen Valera Hawai i Island Coalition Assistant Hawaiʻi Public Health Institute Tobacco/Vape Laws Hawaiʻi Age 21 unlawful to sell or furnish tobacco/vape in any form

More information

There is no such thing as a safe cigarette, and no safe level of exposure to the carcinogens or other toxic substances contained in tobacco smoke.

There is no such thing as a safe cigarette, and no safe level of exposure to the carcinogens or other toxic substances contained in tobacco smoke. POSITION STATEMENT Dangers of reduced-harm cigarettes Smokers considering changing to so-called reduced harm cigarettes should not conclude that these products are a less harmful alternative Key messages

More information

SAFETY DATA SHEET THE BIG CHEESE RAT AND MOUSE KILLER ALL-WEATHER BLOCK BAIT. BAIT (HSE No.: 8794)

SAFETY DATA SHEET THE BIG CHEESE RAT AND MOUSE KILLER ALL-WEATHER BLOCK BAIT. BAIT (HSE No.: 8794) SAFETY DATA SHEET THE BIG CHEESE RAT AND MOUSE KILLER ALL-WEATHER BLOCK (HSE No.: 8794). IDENTIFICATION OF THE SUBSTANCE / PREPARATION AND THE COMPANY Product name Company THE BIG CHEESE RAT AND MOUSE

More information

SAFETY DATA SHEET. 1. Identification of the substance or preparation and the company/ undertaking. In vitro diagnostic product; Laboratory chemical

SAFETY DATA SHEET. 1. Identification of the substance or preparation and the company/ undertaking. In vitro diagnostic product; Laboratory chemical 1. Identification of the substance or preparation and the company/ undertaking 1.1 Product Identifier Product Name: Product Code: Mast Legionella Selectavial (MWY) SV36 1.2 Relevant identified uses of

More information

Development and Validation of a Portable Puffing Topography Analyser

Development and Validation of a Portable Puffing Topography Analyser Development and Validation of a Portable Puffing Topography Analyser Gee J.; Slayford S.; Vas C.; Prasad K CORESTA SSPT 2015 R&D British American Tobacco, Southampton, UK Outline Background & Objective

More information